FACTORS INFLUENCING PROGNOSIS IN MYELOMATOSIS

[1] TREATMENT FOR MULTIPLE MYELOMA - COMBINATION CHEMOTHERAPY WITH DIFFERENT MELPHALAN DOSE REGIMENS [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (09) : 1680 - +

[2] Bergsagel D E, 1967, Adv Cancer Res, V10, P311, DOI 10.1016/S0065-230X(08)60081-0

[3] MANAGEMENT OF MYELOMATOSIS [J]. POSTGRADUATE MEDICAL JOURNAL, 1968, 44 (516) : 803 - &

[4] FEINLEIB M, 1960, J NATL CANCER I, V24, P1259

[5] GALTON DAG, 1968, BRIT J HAEMATOL, V15, P319

[6] Hellwig CA, 1943, ARCH PATHOL, V36, P95

[7] GROWTH RATES AND RESPONSES TO TREATMENT IN HUMAN MYELOMATOSIS [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1969, 16 (06) : 607 - &

[8] INNES J, 1961, LANCET, V1, P239

[9] MARTIN NH, 1961, LANCET, V2, P237

[10] CYCLOPHOSPHAMIDE VS MELPHALAN IN TREATMENT OF PLASMA CELL MYELOMA [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 207 (07): : 1328 - &

[1] TREATMENT FOR MULTIPLE MYELOMA - COMBINATION CHEMOTHERAPY WITH DIFFERENT MELPHALAN DOSE REGIMENS [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (09) : 1680 - +

[2] Bergsagel D E, 1967, Adv Cancer Res, V10, P311, DOI 10.1016/S0065-230X(08)60081-0

[3] MANAGEMENT OF MYELOMATOSIS [J]. POSTGRADUATE MEDICAL JOURNAL, 1968, 44 (516) : 803 - &

[4] FEINLEIB M, 1960, J NATL CANCER I, V24, P1259

[5] GALTON DAG, 1968, BRIT J HAEMATOL, V15, P319

[6] Hellwig CA, 1943, ARCH PATHOL, V36, P95

[7] GROWTH RATES AND RESPONSES TO TREATMENT IN HUMAN MYELOMATOSIS [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1969, 16 (06) : 607 - &

[8] INNES J, 1961, LANCET, V1, P239

[9] MARTIN NH, 1961, LANCET, V2, P237

[10] CYCLOPHOSPHAMIDE VS MELPHALAN IN TREATMENT OF PLASMA CELL MYELOMA [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 207 (07): : 1328 - &